![Ulrika Törn Lausten-Thomsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ulrika Törn Lausten-Thomsen
No más puestos en curso
Historial de carrera de Ulrika Törn Lausten-Thomsen
Antiguos cargos conocidos de Ulrika Törn Lausten-Thomsen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Takara Bio Europe AB
![]() Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Director Financiero/CFO | 01/04/2002 | - |
Oficial de Recursos Humanos | 01/04/2002 | - |
Estadísticas
Internacional
Reino Unido | 2 |
Operativa
Director of Finance/CFO | 1 |
Human Resources Officer | 1 |
Sectorial
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Takara Bio Europe AB
![]() Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |